Unverified listing. Sells through a chat or social channel rather than an assessable storefront. It is left out of our vendor rankings; its published test results still appear on compound leaderboards, marked Unverified. Vendors can change this by publishing verifiable results and a storefront we can assess.

Shanxi Qianyecao Biotech QYC

Score computed from 131 publicly published third-party lab results. Every input links to its source below.

Visit Shanxi Qianyecao Biotech QYC ↗

If you buy through our link or code we may earn a commission. This never affects scores or rank position.

PEPTIDECENSUS SCORE
48
of 100 · 131 verified results
How scoring works

Is Shanxi Qianyecao Biotech QYC legit?

Shanxi Qianyecao Biotech QYC is an unverified PeptideCensus listing. Sells through a chat or social channel rather than an assessable storefront. Its 131 published third-party results still appear on our compound boards, marked Unverified.

The Finnrick directory counts 131 published third-party results for Shanxi Qianyecao Biotech QYC, the latest dated 5 Sept 2026. It appears on 8 compound boards; its best scored placement is #6 on the Sermorelin board, scoring 48 from 3 tests.

Whichever seller you use, match the certificate to the lab's own records before trusting a vial: search its code in the Freedom Diagnostics lookup or check a Janoshik report with its key (how to verify a Janoshik report). A certificate covers one tested batch, so compare its batch number and date with the vial you receive.

Where this vendor ranks

8 compound boards · refreshed daily
CompoundRankScoreTestsPrice/mgLast test
Sermorelin #6 48 3 $2.00 4 Sept 2026
Tesamorelin #8 58 12 $1.90 21 Jul 2026
PT-141 #8 73 3 $1.80 5 Sept 2026
NAD+ #15 19 4 — 4 Aug 2026
Survodutide #17 — — — —
GHK-Cu #19 90 13 $0.08 9 Aug 2026
TB-500 #22 40 4 $3.00 17 Jul 2026
Wolverine #24 — — — —

Every leaderboard placement we track; each row links to the full board and its source record. Rows without scores are rating-level listings the published testing has not yet covered.